Stay updated with the Sun Pharma Stock Liveblog, your one-stop destination for real-time information and analysis of a ...

He is the eldest child of Dilip Shanghvi, chairman and managing director of Sun Pharma, a Rs 4.17 lakh crore market cap ...

Vijayalakshmy Malkani has worked as a brand protection counsel for 20 years before taking on her new role at Sun Pharma ...

Sun Pharmaceutical Industries Ltd. closed 11.40% below its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

"Ahead of the Union Budget 2025 presentation, there could be some volatility in the market. Post-Budget, there may be a ...

Sun Pharma's Q3 earnings may see a slight setback in margins, pressured by increased R&D expenses and a lower contribution ...

The Nifty Pharma index fell nearly 3% in intraday trade on January 28, marking its third consecutive session of decline, with ...

Region’s leading science-focused ecosystem set to explore healthspan and the UAE’s life science achievements at landmark 50th ...

Sun Pharmaceutical Industries Ltd. closed 12.97% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...

Stay informed with the Sun Pharma Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...

The word on San Francisco’s famously hilly streets is that big pharma is ready to go shopping in 2025, following a flurry of ...

New Delhi: Sun Pharma Labs has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug ...